Importance Treatment of locally advanced rectal cancer (LARC) involves neoadjuvant
chemoradiotherapy plus total mesorectal excision and adjuvant chemotherapy. However …

Objectives We evaluate the feasibility of treatment response prediction using MRI‐based pre‐
, post‐, and delta‐radiomic features for locally advanced rectal cancer (LARC) patients …

Background Current guidelines recommend neoadjuvant therapy for patients with stage II or
III rectal cancer. The addition of platinum derivatives to fluoropyrimidine-based …

Background Locally advanced rectal cancer is routinely treated with neo-adjuvant long
course chemoradiotherapy or short course radiotherapy, followed by total mesorectal …

Objectives The aim of this study was to investigate and validate the performance of
individual and ensemble machine learning models (EMLMs) based on magnetic resonance …

Introduction Neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection is the
standard treatment for locally advanced rectal cancer (LARC). Radiomics can be used as …

The treatment of locally advanced rectal cancer (LARC) is a challenging situation for
radiation oncologists and colorectal surgeons. Most current approaches recommend …

Background Tailored neoadjuvant treatment of locally advanced rectal cancer (LARC) may
improve outcomes. The aim of this study was to determine early MRI prognostic parameters …

Background Preoperative chemoradiotherapy with capecitabine is considered as a standard
of care for locally advanced rectal cancer. The “Tratamiento de Tumores Digestivos” group …

Purpose This study aimed to assess complications and outcomes of a new approach, that is,
combining short course radiotherapy (SRT), concurrent and consolidative chemotherapies …